MOLN (Molecular Partners AG) Price-to-Operating-Cash-Flow : (As of Dec. 14, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Molecular Partners AG Price-to-Operating-Cash-Flow?

As of today (2024-12-14), Molecular Partners AG's share price is $5.43. Molecular Partners AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $-2.15. Hence, Molecular Partners AG's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Molecular Partners AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 11 years, Molecular Partners AG's highest Price-to-Operating-Cash-Flow Ratio was 6.51. The lowest was 1.54. And the median was 1.87.

MOLN's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.685
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Molecular Partners AG's Cash Flow from Operations per share for the three months ended in Sep. 2024 was $-0.47. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $-2.15.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -15.80% per year.

During the past 11 years, Molecular Partners AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 68.10% per year. The lowest was -37.30% per year. And the median was -14.65% per year.

Molecular Partners AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Molecular Partners AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Partners AG Price-to-Operating-Cash-Flow Chart

Molecular Partners AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

1.73

Molecular Partners AG Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Molecular Partners AG's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Molecular Partners AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Molecular Partners AG's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Partners AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Molecular Partners AG's Price-to-Operating-Cash-Flow falls into.

Molecular Partners AG Price-to-Operating-Cash-Flow Calculation

Molecular Partners AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	5.43	/	-2.149
	=

Molecular Partners AG's Share Price of today is $5.43.
Molecular Partners AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.15.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Molecular Partners AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Molecular Partners AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Molecular Partners AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Partners AG (NAS:MOLN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

MLLCF:USA MOLNz:UK 0QXX:UK MOLN:Switzerland

Address

Wagistrasse 14, Schlieren, Zurich, CHE, 8952

Website

https://www.molecularpartners.com

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.